Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Dividends Paid - Common (2016 - 2025)

Historic Dividends Paid - Common for Fresenius Medical Care AG (FMS) over the last 17 years, with Q2 2025 value amounting to -$405.4 million.

  • Fresenius Medical Care AG's Dividends Paid - Common fell 2881.64% to -$405.4 million in Q2 2025 from the same period last year, while for Sep 2025 it was $273.1 million, marking a year-over-year decrease of 1739.09%. This contributed to the annual value of $373.1 million for FY2024, which is 552.47% up from last year.
  • According to the latest figures from Q2 2025, Fresenius Medical Care AG's Dividends Paid - Common is -$405.4 million, which was down 2881.64% from -$67.8 million recorded in Q1 2025.
  • Fresenius Medical Care AG's 5-year Dividends Paid - Common high stood at $897.9 million for Q4 2021, and its period low was -$405.4 million during Q2 2025.
  • For the 5-year period, Fresenius Medical Care AG's Dividends Paid - Common averaged around $75.3 million, with its median value being -$79.2 million (2021).
  • In the last 5 years, Fresenius Medical Care AG's Dividends Paid - Common plummeted by 12107.52% in 2021 and then surged by 3094.59% in 2024.
  • Fresenius Medical Care AG's Dividends Paid - Common (Quarter) stood at $897.9 million in 2021, then dropped by 10.11% to $807.1 million in 2022, then fell by 12.39% to $707.2 million in 2023, then grew by 5.52% to $746.2 million in 2024, then plummeted by 154.32% to -$405.4 million in 2025.
  • Its last three reported values are -$405.4 million in Q2 2025, -$67.8 million for Q1 2025, and $746.2 million during Q4 2024.